ORKA
Oruka Therapeutics Inc Earnings Dividend
$63
Earnings Summary
Net Profits | $-29.58Mn |
Highlights
Net Profits:
Oruka Therapeutics Inc’s net profit jumped 11.41% since last year same period to $-29.58Mn in the Q4 2025. On a quarterly growth basis, Oruka Therapeutics Inc has generated 2.29% jump in its net profits since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Oruka Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.62 |
EPS Estimate Current Year | -0.62 |
Highlights
EPS Estimate Current Quarter:
Oruka Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.62 - a 12.06% jump from last quarter’s estimates.
EPS Estimate Current Year:
Oruka Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.62.
Key Ratios
Key ratios of the Oruka Therapeutics Inc post its Q4 2025 earnings
Earning Per Share (EPS) | -0.45 |
Highlights
Earning Per Share (EPS):
Oruka Therapeutics Inc’s earning per share (EPS) jumped 16.67% since last year same period to -0.45 in the Q4 2025. This indicates that the Oruka Therapeutics Inc has generated 16.67% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2025-09-30 | -0.7 | -0.69 | 1.43% |
2025-03-31 | -0.48 | -0.5 | -6.06% |
2025-12-31 | -0.62 | -0.45 | 26.9% |
2025-06-30 | -0.66 | -0.46 | 30.3% |
